Obstructive sleep apnea (OSA) is characterized by a repetitive collapse of the upper airway during sleep and may affect as many as 1 in 5 adults. Although OSA appears to increase risk for metabolic syndrome in middle-aged adults, no data currently exist in a younger, preclinical cohort.
Methods:
Forty-five sedentary young men: 12 overweight with OSA (OSA), 18 overweight without OSA (NOSA), and 15 normal-weight without OSA (CON). Respiratory distress index (RDI) was determined using an at-home, unsupervised, portable polygraphy device. Total and subcutaneous abdominal fat (SAF) were quantified using dual-energy X-ray absorptiometry (DXA). Blood pressure was obtained manually via auscultation. Fasting triglycerides, glucose, and high-density lipoprotein cholesterol (HDL-C) concentrations were analyzed from whole blood using a commercial lipid profile kit.
Results:
The OSA group had 25% more SAF than the NOSA group (P < 0.05) and higher triglycerides (136.7 ± 21.3 mg/dL versus 92.2 ± 7.5, P < 0.05). RDI was directly related to fasting triglycerides (R = 0.32, P < 0.05) after controlling for SAF. The number of metabolic syndrome components was directly correlated to indices of adiposity, but not RDI. Using multiple linear regression analysis, triglycerides were the only independent predictor of RDI.
Conclusions:
Results from this study demonstrate that unique physiologic and anthropometric abnormalities exist in young men with occult OSA, beyond those that are seen in uncomplicated obesity. These findings may indicate early pathogenesis of metabolic syndrome in these young men.
Get full access to this article
View all access options for this article.
References
1.
YoungT, PeppardPE, GottliebDJ. Epidemiology of obstructive sleep apnea: A population health perspective. Am J Respir Crit Care Med, 2002; 165:1217–1239.
HlaKM, YoungTB, BidwellT, PaltaM, SkatrudJB, DempseyJ. Sleep apnea and hypertension. A population-based study. Ann Intern Med, 1994; 120:382–388.
4.
PeppardPE, YoungT, PaltaM, SkatrudJ. Prospective study of the association between sleep-disordered breathing and hypertension. N Engl J Med, 2000; 342:1378–1384.
5.
YoungT, PeppardP, PaltaM, et al.Population-based study of sleep-disordered breathing as a risk factor for hypertension. Arch Intern Med, 1997; 157:1746–1752.
6.
ShaharE, WhitneyCW, RedlineS, et al.Sleep-disordered breathing and cardiovascular disease: Cross-sectional results of the Sleep Heart Health Study. Am J Respir Crit Care Med, 2001; 163:19–25.
7.
CoughlinSR, MawdsleyL, MugarzaJA, CalverleyPM, WildingJP. Obstructive sleep apnoea is independently associated with an increased prevalence of metabolic syndrome. Eur Heart J, 2004; 25:735–741.
8.
GruberA, HorwoodF, SitholeJ, AliNJ, IdrisI. Obstructive sleep apnoea is independently associated with the metabolic syndrome but not insulin resistance state. Cardiovasc Diabetol, 2006; 5:22.
9.
Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation,,and Treatment of High Blood Cholesterol In Adults (Adult Treatment Panel III). JAMA, 2001; 285:2486–2497.
10.
AlbertiKG, ZimmetP, ShawJ. Metabolic syndrome—a new world-wide definition. A Consensus Statement from the International Diabetes Federation. Diabet Med, 2006; 23:469–480.
11.
BalkauB, CharlesMA. Comment on the provisional report from the WHO consultation. European Group for the Study of Insulin Resistance (EGIR). Diabet Med, 1999; 16:442–443.
12.
WHO. Definition, Diagnosis and Classification of Diabetes Mellitus and its Complications. Geneva, 1999.
13.
LakkaHM, LaaksonenDE, LakkaTA, et al.The metabolic syndrome and total and cardiovascular disease mortality in middle-aged men. JAMA, 2002; 288:2709–2716.
14.
SheltonKE, WoodsonH, GayS, SurattPM. Pharyngeal fat in obstructive sleep apnea. Am Rev Respir Dis, 1993; 148:462–466.
15.
ShinoharaE, KiharaS, YamashitaS, et al.Visceral fat accumulation as an important risk factor for obstructive sleep apnoea syndrome in obese subjects. J Intern Med, 1997; 241:11–18.
16.
VgontzasAN, BixlerEO, ChrousosGP. Sleep apnea is a manifestation of the metabolic syndrome. Sleep Med Rev, 2005; 9:211–224.
RajalaMW, SchererPE. Minireview: The adipocyte—at the crossroads of energy homeostasis, inflammation, and atherosclerosis. Endocrinology, 2003; 144:3765–3773.
19.
ArnerP. Insulin resistance in type 2 diabetes—role of the adipokines. Curr Mol Med, 2005; 5:333–339.
20.
FasshauerM, PaschkeR. Regulation of adipocytokines and insulin resistance. Diabetologia, 2003; 46:1594–1603.
21.
KapsimalisF, RichardsonG, OppMR, KrygerM. Cytokines and normal sleep. Curr Opin Pulm Med, 2005; 11:481–484.
22.
OppMR. Cytokines and sleep. Sleep Med Rev, 2005; 9:355–364.
23.
VgontzasAN, PapanicolaouDA, BixlerEO, et al.Sleep apnea and daytime sleepiness and fatigue: relation to visceral obesity, insulin resistance, and hypercytokinemia. J Clin Endocrinol Metab, 2000; 85:1151–1158.
24.
HarschIA, SchahinSP, Radespiel-TrogerM, et al.Continuous positive airway pressure treatment rapidly improves insulin sensitivity in patients with obstructive sleep apnea syndrome. Am J Respir Crit Care Med, 2004; 169:156–162.
25.
NewmanAB, NietoFJ, GuidryU, et al.Relation of sleep-disordered breathing to cardiovascular disease risk factors: the Sleep Heart Health Study. Am J Epidemiol, 2001; 154:50–59.
26.
MillerTD, BaladyGJ, FletcherGF. Exercise and its role in the prevention and rehabilitation of cardiovascular disease. Ann Behav Med, 1997; 19:220–229.
27.
KalethAS, ChittendenTW, HawkinsBJ, et al.Unique cardiopulmonary exercise test responses in overweight middle-aged adults with obstructive sleep apnea. Sleep Med, 2007; 8:160–168.
28.
Sleep-related breathing disorders in adults: Recommendations for syndrome definition and measurement techniques in clinical research. The Report of an American Academy of Sleep Medicine Task Force. Sleep, 1999; 22:667–689.
29.
JohnsMW. A new method for measuring daytime sleepiness: The Epworth sleepiness scale. Sleep, 1991; 14:540–545.
30.
FossatiP, PrencipeL. Serum triglycerides determined colorimetrically with an enzyme that produces hydrogen peroxide. Clin Chem, 1982; 28:2077–2080.
31.
WarnickGR, BendersonJ, AlbersJJ. Dextran sulfate-Mg2+ precipitation procedure for quantitation of high density-lipoprotein cholesterol. Selected Methods Clin Chem, 1983; 10:91–99.
32.
KamelEG, McNeillG, VanWijk MC. Usefulness of anthropometry and DXA in predicting intra-abdominal fat in obese men and women. Obes Res, 2000;8:36–42.
33.
Nickols-RichardsonSM, MillerLE, WoottenDF, et al.Distal tibia areal bone mineral density: Use in detecting low aBMD of the hip in young women. J Clin Densitom, 2005; 8:74–79.
34.
ChasensER, WeaverTE, UmlaufMG. Insulin resistance and obstructive sleep apnea: is increased sympathetic stimulation the link?. Biol Res Nurs, 2003; 5:87–96.
35.
CavagniniF, CrociM, PutignanoP, PetroniML, InvittiC. Glucocorticoids and neuroendocrine function. Int J Obes Relat Metab Disord, 2000; 24,(Suppl 2):S77–S79.
36.
IpMS, LamKS, HoC, TsangKW, LamW. Serum leptin and vascular risk factors in obstructive sleep apnea. Chest, 2000; 118:580–586.
37.
LiJ, ThorneLN, PunjabiNM, et al.Intermittent hypoxia induces hyperlipidemia in lean mice. Circ Res, 2005; 97:698–706.
38.
FantuzziG and MazzoneT. Adipose tissue and atherosclerosis: Exploring the connection. Arterioscler Thromb Vasc Biol, 2007; 27:996–1003.
39.
CareyDG, JenkinsAB, CampbellLV, FreundJ, ChisolmDJ. Abdominal fat and insulin resistance in normal and overweight women: Direct measurements reveal a strong relationship in subjects at both low and high risk of NIDDM. Diabetes, 1996; 45:633–638.
40.
MorrisonJA, FriedmanLA, HarlanWR, et al.Development of the metabolic syndrome in black and white adolescent girls: a longitudinal assessment. Pediatrics, 2005;116,(5):1178–1182.
41.
FukuchiS, HamaguchiK, SeikeM, HimenoK, SakataT, YoshimatsuH. Role of fatty acid composition in the development of metabolic disorders in sucrose-induced obese rats. Exp Biol Med, 2004; 229:486–493.
42.
DingliK, ColemanEL, VennelleM, et al.Evaluation of a portable device for diagnosing the sleep apnoea/hypopnoea syndrome. Eur Respir J, 2003; 21:253–259.
43.
SiegelMJ, HildeboltCF, BaeKT, HongC, WhiteNH. Total and intraabdominal fat distribution in preadolescents and adolescents: measurement with MR imaging. Radiology, 2007; 242:846–856.
